These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 18191382)

  • 1. The sphingolipid salvage pathway in ceramide metabolism and signaling.
    Kitatani K; Idkowiak-Baldys J; Hannun YA
    Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of altered sphingolipid acyl chain length on various disease models.
    Park WJ; Park JW
    Biol Chem; 2015 Jun; 396(6-7):693-705. PubMed ID: 25720066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
    Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
    Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.
    Hajj C; Becker-Flegler KA; Haimovitz-Friedman A
    Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramide synthases at the centre of sphingolipid metabolism and biology.
    Mullen TD; Hannun YA; Obeid LM
    Biochem J; 2012 Feb; 441(3):789-802. PubMed ID: 22248339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide synthases as potential targets for therapeutic intervention in human diseases.
    Park JW; Park WJ; Futerman AH
    Biochim Biophys Acta; 2014 May; 1841(5):671-81. PubMed ID: 24021978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of sphingolipid metabolism: from synthesis to breakdown.
    Gault CR; Obeid LM; Hannun YA
    Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.
    Gangoiti P; Camacho L; Arana L; Ouro A; Granado MH; Brizuela L; Casas J; Fabriás G; Abad JL; Delgado A; Gómez-Muñoz A
    Prog Lipid Res; 2010 Oct; 49(4):316-34. PubMed ID: 20193711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingolipids in mammalian cell signalling.
    Ohanian J; Ohanian V
    Cell Mol Life Sci; 2001 Dec; 58(14):2053-68. PubMed ID: 11814056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids.
    Kono M; Dreier JL; Ellis JM; Allende ML; Kalkofen DN; Sanders KM; Bielawski J; Bielawska A; Hannun YA; Proia RL
    J Biol Chem; 2006 Mar; 281(11):7324-31. PubMed ID: 16380386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
    Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipid metabolic changes during chiral C2-ceramides induced apoptosis in human leukemia cells.
    Baek MY; Yoo HS; Nakaya K; Moon DC; Lee YM
    Arch Pharm Res; 2001 Apr; 24(2):144-9. PubMed ID: 11339634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to tools and techniques for ceramide-centered research.
    Kitatani K; Luberto C
    Adv Exp Med Biol; 2010; 688():276-85. PubMed ID: 20919662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space.
    Tani M; Ito M; Igarashi Y
    Cell Signal; 2007 Feb; 19(2):229-37. PubMed ID: 16963225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sphingolipid-mediated apoptotic signaling pathways].
    Cuvillier O; Andrieu-Abadie N; Ségui B; Malagarie-Cazenave S; Tardy C; Bonhoure E; Levade T
    J Soc Biol; 2003; 197(3):217-21. PubMed ID: 14708343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
    Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
    Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel jaspine B-ceramide hybrid modulates sphingolipid metabolism.
    Garcia V; Le Faouder P; Dupuy A; Levade T; Ballereau S; Génisson Y
    Chem Biodivers; 2015 Jul; 12(7):1115-25. PubMed ID: 26172331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
    Gatt S; Dagan A
    Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins.
    Merrill AH; Sullards MC; Wang E; Voss KA; Riley RT
    Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):283-9. PubMed ID: 11359697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic applications of bioactive sphingolipids in hematological malignancies.
    Ekiz HA; Baran Y
    Int J Cancer; 2010 Oct; 127(7):1497-506. PubMed ID: 20503271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.